MedShift, a medical technology company, secured $89.5 million in debt financing led by Huntington Bank and up to $200 million of capital commitments in a special purpose financing vehicle led by Stonehenge Structured Finance Partners and Blystone & Donaldson. The initial transaction closed on Oct. 18, 2024, and the combined $289.5 million of total potential funding provides MedShift with access to sufficient capital to support its long-term future growth._x000D_
_x000D_
B&D Capital Partners served as the financial advisor to MedShift in arranging, structuring and negotiating the debt financing.
Forward for Specialty Finance
